{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:12:43Z","timestamp":1794370363256,"version":"4.9.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ebiom.2020.102991","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T01:13:27Z","timestamp":1600218807000},"page":"102991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-9512","authenticated-orcid":false,"given":"Rahul","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemalatha","family":"Beesetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajgokul K.","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf A.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-2248","authenticated-orcid":false,"given":"Sathyamangalam","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102991_bib0001","series-title":"Fields Virology","first-page":"747","article-title":"Flaviviruses","author":"Pierson","year":"2013"},{"key":"10.1016\/j.ebiom.2020.102991_bib0002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102991_bib0003","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.ebiom.2020.102991_bib0004","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol Reviews"},{"key":"10.1016\/j.ebiom.2020.102991_bib0006","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102991_bib0007","doi-asserted-by":"crossref","first-page":"e2412","DOI":"10.1371\/journal.pntd.0002412","article-title":"Factors associated with dengue shock syndrome: a systematic review and meta-analysis","volume":"7","author":"Huy","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2020.102991_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006091","article-title":"Symptoms associated with adverse dengue fever prognoses at the time of reporting in the 2015 dengue outbreak in Taiwan","volume":"11","author":"Yeh","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2020.102991_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161884","article-title":"Mortality predictors in patients with severe dengue in the state of Amazonas, Brazil","volume":"11","author":"Pinto","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2020.102991_bib0010","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/iai.36.3.1036-1041.1982","article-title":"Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants","volume":"36","author":"Brandt","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.ebiom.2020.102991_bib0011","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102991_bib0012","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102991_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2020.102991_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2020.102991_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2020.102991_bib0016","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S1020-49892002000400003","article-title":"Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks","volume":"11","author":"Guzman","year":"2002","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.ebiom.2020.102991_bib0017","first-page":"126","article-title":"Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent","volume":"17","author":"Kouri","year":"1983","journal-title":"Bull Pan Am Health Organ"},{"key":"10.1016\/j.ebiom.2020.102991_bib0018","first-page":"375","article-title":"Dengue haemorrhagic fever\/dengue shock syndrome: lessons from the Cuban epidemic, 1981","volume":"67","author":"Kouri","year":"1989","journal-title":"Bull WHO"},{"key":"10.1016\/j.ebiom.2020.102991_bib0019","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4269\/ajtmh.1990.42.179","article-title":"Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study","volume":"42","author":"Guzman","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2020.102991_bib0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102991_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwf005","article-title":"Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand","volume":"156","author":"Endy","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0022","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102991_bib0023","doi-asserted-by":"crossref","first-page":"e45302","DOI":"10.15252\/embr.201745302","article-title":"The bright and dark side of human antibody responses to flaviviruses: lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ebiom.2020.102991_bib0024","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2020.102991_bib0025","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JVI.06335-11","article-title":"Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following Infection","volume":"86","author":"Smith","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0026","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1128\/JVI.00247-14","article-title":"Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones","volume":"88","author":"Smith","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0027","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YF17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2020.102991_bib0028","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102991_bib0029","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/14760584.2016.1128328","article-title":"A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone","volume":"15","author":"Osorio","year":"2016","journal-title":"Exp Rev Vac"},{"key":"10.1016\/j.ebiom.2020.102991_bib0030","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102991_bib0031","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1016\/j.vaccine.2011.07.023","article-title":"Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine","volume":"29","author":"Durbin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2020.102991_bib0032","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","article-title":"Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine: What makes this vaccine different from the Sanofi-Pasteur CYDTM vaccine?","volume":"15","author":"Whitehead","year":"2016","journal-title":"Exp Rev Vac"},{"key":"10.1016\/j.ebiom.2020.102991_bib0033","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14760584.2017.1335201","article-title":"A recombinant live attenuated tetravalent vaccine for the prevention of dengue","volume":"16","author":"Guy","year":"2017","journal-title":"Expert Rev Vaccine"},{"key":"10.1016\/j.ebiom.2020.102991_bib0034","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030700","article-title":"Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? There is only one true winner","volume":"10","author":"Halstead","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0035","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","article-title":"Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age","volume":"35","author":"Halstead","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2020.102991_bib0036","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102991_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006191","article-title":"A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice","volume":"12","author":"Ramasamy","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2020.102991_bib0038","doi-asserted-by":"crossref","first-page":"aaf8160","DOI":"10.1126\/science.aaf8160","article-title":"Assessing the global threat from Zika virus","volume":"353","author":"Lessler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102991_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.001","article-title":"The immunopathology of dengue and Zika virus infections","volume":"48","author":"Culshaw","year":"2017","journal-title":"Current Opin Immunol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102991_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2019.01.005","article-title":"Dengue virus immunity increases Zika virus-induced damage during pregnancy","volume":"50","author":"Brown","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2020.102991_bib0042","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1128\/JVI.03827-13","article-title":"Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines","volume":"88","author":"Zust","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0043","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization","volume":"45","author":"Kraus","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0044","doi-asserted-by":"crossref","first-page":"ftz026","DOI":"10.1093\/femspd\/ftz026","article-title":"Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation","volume":"77","author":"Shanmugam","year":"2019","journal-title":"Pathogens Dis"},{"key":"10.1016\/j.ebiom.2020.102991_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12896-016-0243-3","article-title":"Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris","volume":"16","author":"Kaushik","year":"2016","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102738","article-title":"Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement","volume":"54","author":"Shukla","year":"2020","journal-title":"EBioMed"},{"key":"10.1016\/j.ebiom.2020.102991_bib0047","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102991_bib0048","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1084\/jem.20170957","article-title":"Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice","volume":"214","author":"Cao","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2020.102991_bib0049","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live attenuated, tetravalent dengue vaccine (CYD-TDV) in na\u00efve and dengue-exposed individuals","volume":"125","author":"Henein","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102991_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000171","article-title":"A prospective nested case-control study of dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model","volume":"6","author":"Libraty","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ebiom.2020.102991_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"De Alwis","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2020.102991_bib0052","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00705-010-0741-x","article-title":"Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus","volume":"155","author":"Ito","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0053","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1016\/j.vaccine.2017.09.063","article-title":"Elaboration of tetravalent antibody response against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence","volume":"35","author":"Sun","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2020.102991_bib0054","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0056","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0057","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for Flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102991_bib0058","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouce Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"MABS"},{"key":"10.1016\/j.ebiom.2020.102991_bib0059","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JVI.01320-14","article-title":"A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease","volume":"89","author":"Sarathy","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125476","article-title":"A dengue virus type 4 model of disseminated lethal infection in AG129 mice","volume":"10","author":"Milligan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2020.102991_bib0061","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/jgv.0.000923","article-title":"A lethal model of disseminated dengue virus type 1 infection in AG129 mice","volume":"98","author":"Milligan","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006258","article-title":"A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses","volume":"13","author":"Tripathi","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2020.102991_bib0063","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0064","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102991_bib0065","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102991_bib0066","doi-asserted-by":"crossref","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102991_bib0067","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.4049\/jimmunol.176.6.3821","article-title":"T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?","volume":"176","author":"Mongkolsapaya","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2020.102991_bib0068","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102991_bib0069","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.2016.1121814","article-title":"Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development","volume":"15","author":"Acosta","year":"2016","journal-title":"Expert Rev Vaccines"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:01:00Z","timestamp":1762455660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420303674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":69,"alternative-id":["S2352396420303674"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102991","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102991"}}